Clinical trial
A Brief Automated Neurocognitive Training to Enhance the Real-World Impact of Ketamine's Rapid Antidepressant Effect
NCT06526078 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Brief Automated Neurocognitive Training to Enhance the Real-World Impact of Ketamine's Rapid Antidepressant Effect
- Lead sponsor
- University of Pittsburgh
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 12, 2024
- Completion date
- May 31, 2029
- Enrollment
- 600 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
depression